Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats
- PMID: 1356587
- DOI: 10.1016/0006-8993(92)91361-h
Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats
Abstract
The extracellular levels of gamma-aminobutyric acid (GABA) in the caudate-putamen and the nucleus accumbens of rats following administration of haloperidol decanoate, fluphenazine decanoate, or vehicle for 8 months were assessed using intracranial microdialysis. Basal levels of extracellular GABA were significantly decreased in the nucleus accumbens of both neuroleptic-treated groups while levels of GABA in the caudate-putamen were not significantly different between groups. These results provide evidence for selective chronic neuroleptic-induced effects on in vivo GABA function in different terminal regions containing dopamine receptors.
Similar articles
-
Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex.Neuroreport. 1995 Sep 11;6(13):1795-8. doi: 10.1097/00001756-199509000-00021. Neuroreport. 1995. PMID: 8541484
-
Regional differences in chronic neuroleptic effects on extracellular dopamine activity.Brain Res Bull. 1992 Sep-Oct;29(3-4):473-8. doi: 10.1016/0361-9230(92)90085-c. Brain Res Bull. 1992. PMID: 1382815
-
Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.Neuroscience. 1996 May;72(1):99-104. doi: 10.1016/0306-4522(95)00540-4. Neuroscience. 1996. PMID: 8730709
-
Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs.Ann N Y Acad Sci. 1992;668:54-69. doi: 10.1111/j.1749-6632.1992.tb27339.x. Ann N Y Acad Sci. 1992. PMID: 1361120 Review.
-
Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies.Ann N Y Acad Sci. 1992;668:146-56. doi: 10.1111/j.1749-6632.1992.tb27346.x. Ann N Y Acad Sci. 1992. PMID: 1361110 Review. No abstract available.
Cited by
-
Access to the CNS: Biomarker Strategies for Dopaminergic Treatments.Pharm Res. 2018 Feb 15;35(3):64. doi: 10.1007/s11095-017-2333-x. Pharm Res. 2018. PMID: 29450650 Free PMC article. Review.
-
Region-specific and dose-specific effects of chronic haloperidol exposure on [3H]-flumazenil and [3H]-Ro15-4513 GABAA receptor binding sites in the rat brain.Eur Neuropsychopharmacol. 2020 Dec;41:106-117. doi: 10.1016/j.euroneuro.2020.10.004. Epub 2020 Nov 2. Eur Neuropsychopharmacol. 2020. PMID: 33153853 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources